Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3865Neoplasms 2990Prostatic Neoplasms 1754Colorectal Neoplasms 1431Lung Neoplasms 1331Motor Activity 805Head and Neck Neoplasms 686Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Hepatocellular 632Carcinoma, Non-Small-Cell Lung 631Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 486Ovarian Neoplasms 441Anxiety Disorders 420Pain 419Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 376Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 340Melanoma 323Multiple Myeloma 322Lymphoma 306Depression 306Endometrial Neoplasms 290Liver Neoplasms 280

Interventions

Injections, Intralesional 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Interventional × Lymphangioma, Cystic × Clear all
NCT07246928 2026-04-30

US: Ultrasound

Delta University for Science and Technology

Phase NA Completed
1 enrolled

Lymphangioma, Cystic

NCT07189832 2026-04-28

Bleomycin Intralesional Injections of Cystic Hygromas

Delta University for Science and Technology

Phase NA Completed
30 enrolled

Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡